4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-011651
Chief Financial Officer sold 6,628 shares at an average $106.03 ($702,744)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2026-02-04 | Sale 10b5-1 | −1,500 | $104.74 | $157,115 | 130,665 | D: show line 1 in the form |
| Smith Hunter C Chief Financial Officer | 2026-02-04 | Sale 10b5-1 | −1,000 | $106.60 | $106,604 | 129,665 | D: show line 2 in the form |
| Smith Hunter C Chief Financial Officer | 2026-02-04 | Sale 10b5-1 | −747 | $107.67 | $80,426 | 128,918 | D: show line 3 in the form |
| Smith Hunter C Chief Financial Officer | 2026-02-05 | Sale 10b5-1 | −3,381 | $106.06 | $358,599 | 125,537 | D: show line 4 in the form |
| Open-market sales · 6,628 sh · avg $106.03 · $702,744 | |||||||
Loading xslF345X05/tm265467-1_4seq1.xml…